243 related articles for article (PubMed ID: 23131389)
1. From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma.
Thomas A; Rajan A; Lopez-Chavez A; Wang Y; Giaccone G
Ann Oncol; 2013 Mar; 24(3):577-85. PubMed ID: 23131389
[TBL] [Abstract][Full Text] [Related]
2. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
3. Is tissue still the issue in detecting molecular alterations in lung cancer?
Liam CK; Mallawathantri S; Fong KM
Respirology; 2020 Sep; 25(9):933-943. PubMed ID: 32335992
[TBL] [Abstract][Full Text] [Related]
4. Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.
Sabari JK; Santini F; Bergagnini I; Lai WV; Arbour KC; Drilon A
Curr Oncol Rep; 2017 Apr; 19(4):24. PubMed ID: 28303491
[TBL] [Abstract][Full Text] [Related]
5. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Mack PC; Banks KC; Espenschied CR; Burich RA; Zill OA; Lee CE; Riess JW; Mortimer SA; Talasaz A; Lanman RB; Gandara DR
Cancer; 2020 Jul; 126(14):3219-3228. PubMed ID: 32365229
[TBL] [Abstract][Full Text] [Related]
7. Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.
Canberk S; Engels M
Virchows Arch; 2021 Jan; 478(1):45-57. PubMed ID: 33389149
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
Aggarwal C; Thompson JC; Black TA; Katz SI; Fan R; Yee SS; Chien AL; Evans TL; Bauml JM; Alley EW; Ciunci CA; Berman AT; Cohen RB; Lieberman DB; Majmundar KS; Savitch SL; Morrissette JJD; Hwang WT; Elenitoba-Johnson KSJ; Langer CJ; Carpenter EL
JAMA Oncol; 2019 Feb; 5(2):173-180. PubMed ID: 30325992
[TBL] [Abstract][Full Text] [Related]
9. Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?
Roberts PJ; Stinchcombe TE; Der CJ; Socinski MA
J Clin Oncol; 2010 Nov; 28(31):4769-77. PubMed ID: 20921461
[TBL] [Abstract][Full Text] [Related]
10. Tissue sampling in lung cancer: a review in light of the MERIT experience.
Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J
Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788
[TBL] [Abstract][Full Text] [Related]
11. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
[TBL] [Abstract][Full Text] [Related]
12. Innovative Clinical Trials: The LUNG-MAP Study.
Steuer CE; Papadimitrakopoulou V; Herbst RS; Redman MW; Hirsch FR; Mack PC; Ramalingam SS; Gandara DR
Clin Pharmacol Ther; 2015 May; 97(5):488-91. PubMed ID: 25676724
[TBL] [Abstract][Full Text] [Related]
13. A decade of advances in treatment for advanced non-small cell lung cancer.
Gettinger S; Lynch T
Clin Chest Med; 2011 Dec; 32(4):839-51. PubMed ID: 22054890
[TBL] [Abstract][Full Text] [Related]
14. Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC.
He Y; Chen L; Zhao L; Dang S; Liu G; Sasada S; Ma PC; van Zandwijk N; Rosell R; Popper HH; Wang H; Jiang M; Guo H; Liu X; Chen S; Zhang X; Xu M; Zhu B; Liu M; Zhou C
Theranostics; 2021; 11(14):7092-7109. PubMed ID: 34093873
[No Abstract] [Full Text] [Related]
15. Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Zhao Y; Dong Y; Zhao R; Zhang B; Wang S; Zhang L; Hu M; He Q; Zhang W; Han B
Clin Lung Cancer; 2020 Sep; 21(5):e355-e362. PubMed ID: 32139332
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.
Dolly SO; Collins DC; Sundar R; Popat S; Yap TA
Drugs; 2017 May; 77(8):813-827. PubMed ID: 28378229
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
Moore DA; Balbi K; Ingham A; Arkenau HT; Bennett P
J Clin Pathol; 2018 Nov; 71(11):1001-1006. PubMed ID: 30054375
[TBL] [Abstract][Full Text] [Related]
18. Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles.
Visser S; Hou J; Bezemer K; de Vogel LL; Hegmans JPJJ; Stricker BH; Philipsen S; Aerts JGJV
BMC Cancer; 2019 May; 19(1):440. PubMed ID: 31088547
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of afatinib-resistant non-small cell lung cancer cells in vivo derived from mice.
Chung CT; Yeh KC; Lee CH; Chen YY; Ho PJ; Chang KY; Chen CH; Lai YK; Chen CT
Pharmacol Res; 2020 Nov; 161():105183. PubMed ID: 32896579
[TBL] [Abstract][Full Text] [Related]
20. Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021.
Pisapia P; Costa JL; Pepe F; Russo G; Gragnano G; Russo A; Iaccarino A; de Miguel-Perez D; Serrano MJ; Denninghoff V; Quagliata L; Rolfo C; Malapelle U
Crit Rev Oncol Hematol; 2021 May; 161():103311. PubMed ID: 33781866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]